SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yan Hong Wang, Ben Quan Wu, Hui Liu, Continuous venovenous hemodiafiltration for hyperlactatemia caused by telbivudine in a patient with chronic hepatitis B: A case report and update review, Journal of Digestive Diseases, 2015, 16, 3
  2. 2
    Ming-Ling Chang, Yun-Fan Liaw, Hepatitis B flares in chronic hepatitis B: Pathogenesis, natural course, and management, Journal of Hepatology, 2014, 61, 6, 1407

    CrossRef

  3. 3
    Lin Ma, Nageswara R. Alla, Xiaomao Li, Ospan A. Mynbaev, Zhongjie Shi, Mother-to-child transmission of HBV: review of current clinical management and prevention strategies, Reviews in Medical Virology, 2014, 24, 6
  4. 4
    Jian Sun, Qing Xie, Deming Tan, Qin Ning, Junqi Niu, Xuefan Bai, Rong Fan, Shijun Chen, Jun Cheng, Yanyan Yu, Hao Wang, Min Xu, Guangfeng Shi, Mobin Wan, Xinyue Chen, Hong Tang, Jifang Sheng, Xiaoguang Dou, Junping Shi, Hong Ren, Maorong Wang, Hongfei Zhang, Zhiliang Gao, Chengwei Chen, Hong Ma, Jidong Jia, Jinlin Hou, The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: A randomized, controlled study, Hepatology, 2014, 59, 4
  5. 5
    Ji-Dong Jia, Jin-Lin Hou, You-Kuan Yin, De-Ming Tan, Daozhen Xu, Jun-Qi Niu, Xia-Qiu Zhou, Yu-Ming Wang, Li-Min Zhu, Cheng-Wei Chen, Yong-Wen He, Hong Ren, Mo-Bin Wan, Shan-Ming Wu, Qin-Huan Wang, Lai Wei, Weibin Bao, Yuhong Dong, Aldo Trylesinski, Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients, Hepatology International, 2014, 8, 1, 72

    CrossRef

  6. 6
    Astrid Wiens, Luana Lenzi, Rafael Venson, Cassyano J. Correr, Inajara Rotta, Maria L. Pedroso, Roberto Pontarolo, Comparative Efficacy of Oral Nucleoside or Nucleotide Analog Monotherapy Used in Chronic Hepatitis B: A Mixed-Treatment Comparison Meta-analysis, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013, 33, 2
  7. 7
    Astrid Wiens, Luana Lenzi, Rafael Venson, Maria Lúcia Alves Pedroso, Cassyano Januário Correr, Roberto Pontarolo, Economic evaluation of treatments for chronic hepatitis B, The Brazilian Journal of Infectious Diseases, 2013, 17, 4, 418

    CrossRef

  8. You have free access to this content8
    Y. Wang, S. Thongsawat, E. J. Gane, Y.-F. Liaw, J. Jia, J. Hou, H. L. Y. Chan, G. Papatheodoridis, M. Wan, J. Niu, W. Bao, A. Trylesinski, N. V. Naoumov, Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B, Journal of Viral Hepatitis, 2013, 20, 4
  9. 9
    Jian Liang, Man Jun Jiang, Xin Deng, Xiao Xiao Zhou, Efficacy and Safety of Telbivudine Compared to Entecavir Among HBeAg+ Chronic Hepatitis B Patients: a Meta-Analysis Study, Hepatitis Monthly, 2013, 13, 5

    CrossRef

  10. 10
    Y. Li, Y. Zhang, J.-P. Wang, J.-Q. Lian, X.-F. Bai, Efficacy of telbivudine treatment for hepatitis B e antigen-positive chronic hepatitis B patients with poor response to adefovir dipivoxil, Journal of Viral Hepatitis, 2013, 20,
  11. 11
    Z. Han, Y. Shi, J. Zhu, Y. Chen, F. Yin, L. Xia, G. Luo, Z. Gao, J. Liu, G. Jia, C. Li, X. Zhou, Y. Han, Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis, Journal of Viral Hepatitis, 2013, 20,
  12. 12
    Chih-Lin Lin, Jia-Horng Kao, Hepatitis B viral factors and treatment responses in chronic hepatitis B, Journal of the Formosan Medical Association, 2013, 112, 6, 302

    CrossRef

  13. 13
    Chih-Lin Lin, Jia-Horng Kao, Hepatitis B Virus Genotypes: Clinical Relevance and Therapeutic Implications, Current Hepatitis Reports, 2013, 12, 2, 124

    CrossRef

  14. 14
    Chunqiu Hao, Jiuping Wang, Wenzhen Kang, Yumei Xie, Yun Zhou, Li Ma, Meijuan Peng, Xuefan Bai, Jianqi Lian, Zhansheng Jia, Kinetics of Th17 Cytokines During Telbivudine Therapy in Patients With Chronic Hepatitis B, Viral Immunology, 2013, 26, 5, 336

    CrossRef

  15. 15
    H. Jiang, J. Wang, W. Zhao, Lamivudine versus telbivudine in the treatment of chronic hepatitis B: a systematic review and meta-analysis, European Journal of Clinical Microbiology & Infectious Diseases, 2013, 32, 1, 11

    CrossRef

  16. 16
    Brian Lin, Nghiem B Ha, Anne Liu, Huy N Trinh, Huy A Nguyen, Khanh K Nguyen, Aijaz Ahmed, Emmet B Keeffe, Ruel T Garcia, Gabriel Garcia, Mindie H Nguyen, Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice, Journal of Gastroenterology and Hepatology, 2013, 28, 5
  17. 17
    D.J.W. Wesdorp, M. Knoester, A.E. Braat, M.J. Coenraad, A.C.T.M. Vossen, E.C.J. Claas, B. van Hoek, Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective, Journal of Clinical Virology, 2013, 58, 1, 67

    CrossRef

  18. 18
    En Qiang Chen, Lang Bai, Lan Lan Chen, Tao You Zhou, Ling Yao Du, Hong Tang, Prolonged Combination Therapy is More Effective than Monotherapy in Management of Chronic Hepatitis B Patients With Sustained Virological Response: An Experience From a ‘Real-World’ Clinical Setting, Iranian Red Crescent Medical Journal, 2013, 15, 12

    CrossRef

  19. 19
    H. You, J. Jia, Telbivudine treatment in chronic hepatitis B: experience from China, Journal of Viral Hepatitis, 2013, 20,
  20. 20
    G.-Q. Wang, Y.-P. Ding, Y.-H. Dong, Telbivudine treatment is associated with high hepatitis B e antigen seroconversion and immune modulatory effects in chronic hepatitis B patients, Journal of Viral Hepatitis, 2013, 20,
  21. You have free access to this content21
    Hong Ma, Jidong Jia, Why do I treat HBeAg-positive chronic hepatitis B patients with a Nucleoside analogue, Liver International, 2013, 33,
  22. 22
    Yun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, Henry Lik Yuen Chan, Rong-Nan Chien, Chun-Jen Liu, Ed Gane, Stephen Locarnini, Seng-Gee Lim, Kwang-Hyub Han, Deepak Amarapurkar, Graham Cooksley, Wasim Jafri, Rosmawati Mohamed, Jin-Lin Hou, Wan-Long Chuang, Laurentius A. Lesmana, Jose D. Sollano, Dong-Jin Suh, Masao Omata, Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update, Hepatology International, 2012, 6, 3, 531

    CrossRef

  23. 23
    Jing He, James M. Bowen, Feng Xie, Ron Goeree, Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada, Value in Health, 2012, 15, 6, 894

    CrossRef

  24. 24
    Yanhua Zheng, Zemin Huang, Xianhua Chen, Yi Tian, Jun Tang, Yi Zhang, Xiaomin Zhang, Jijun Zhou, Qing Mao, Bing Ni, Qinghong Wang, Yuzhang Wu, Effects of Telbivudine Treatment on the Circulating CD4+T-Cell Subpopulations in Chronic Hepatitis B Patients, Mediators of Inflammation, 2012, 2012, 1

    CrossRef

  25. 25
    Kaushal Madan, Pankaj Tyagi, Hepatitis B Virus Genotyping: Is the Time Ripe for Routine Clinical Use?, Journal of Clinical and Experimental Hepatology, 2012, 2, 2, 174

    CrossRef

  26. 26
    Cheng Wang, Rong Fan, Jian Sun, Jinlin Hou, Prevention and management of drug resistant hepatitis B virus infections, Journal of Gastroenterology and Hepatology, 2012, 27, 9
  27. 27
    H. L.Y. Chan, Y. C. Chen, E. J. Gane, S. K. Sarin, D. J. Suh, T. Piratvisuth, B. Prabhakar, S. G. Hwang, G. Choudhuri, R. Safadi, T. Tanwandee, A. Chutaputti, C. Yurdaydin, W. Bao, C. Avila, A. Trylesinski, Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis, Journal of Viral Hepatitis, 2012, 19, 10
  28. 28
    Arianeb Mehrabi, Majid Esmaeilzadeh, Hamidreza Fonouni, Mohammadreza Hafezi, Nuh N. Rahbari, Mohammad Golriz, Ali Majlesara, Morva Tahmasbi Rad, Mahmoud Sadeghi, Jan Schmidt, Tom M. Ganten, The role of HBIg as hepatitis B reinfection prophylaxis following liver transplantation, Langenbeck's Archives of Surgery, 2012, 397, 5, 697

    CrossRef

  29. 29
    Behzad Einollahi, Therapy for HBV Infection in Hemodialysis Patients: Is it Possible?, Hepatitis Monthly, 2012, 12, 3, 153

    CrossRef

  30. 30
    F. Ji, B. Yang, X. Peng, H. Ding, H. You, P. Tien, Circulating microRNAs in hepatitis B virus–infected patients, Journal of Viral Hepatitis, 2011, 18, 7
  31. 31
    Yu Wang, Jidong Jia, Control of hepatitis B in China: prevention and treatment, Expert Review of Anti-infective Therapy, 2011, 9, 1, 21

    CrossRef

  32. 32
    Astrid Wiens, Rafael Venson, Cassyano Januário Correr, Roberto Pontarolo, Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B, The Brazilian Journal of Infectious Diseases, 2011, 15, 3, 225

    CrossRef

  33. 33
    Yuk-Fai Lam, Man-Fung Yuen, Wai-Kay Seto, Ching-Lung Lai, Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety, Current Hepatitis Reports, 2011, 10, 4, 235

    CrossRef

  34. 34
    J. Fung, C.-L. Lai, W.-K. Seto, M.-F. Yuen, Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B, Journal of Antimicrobial Chemotherapy, 2011, 66, 12, 2715

    CrossRef

  35. 35
    Chih-Lin Lin, Jia-Horng Kao, Recent advances in the treatment of chronic hepatitis B, Expert Opinion on Pharmacotherapy, 2011, 12, 13, 2025

    CrossRef

  36. 36
    Wai-Kay Seto, Ching-Lung Lai, James Fung, Danny Ka-Ho Wong, John Chi-Hang Yuen, Ivan Fan-Ngai Hung, Man-Fung Yuen, Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome, Journal of Hepatology, 2011, 55, 3, 522

    CrossRef

  37. 37
    Tatyana A. Shamliyan, James R. Johnson, Roderick MacDonald, Aasma Shaukat, Jian-Min Yuan, Robert L. Kane, Timothy J. Wilt, Systematic Review of the Literature on Comparative Effectiveness of Antiviral Treatments for Chronic Hepatitis B Infection, Journal of General Internal Medicine, 2011, 26, 3, 326

    CrossRef

  38. 38
    Chih-Lin Lin, Jia-Horng Kao, The clinical implications of hepatitis B virus genotype: Recent advances, Journal of Gastroenterology and Hepatology, 2011, 26,
  39. 39
    Myron J. Tong, Calvin Q. Pan, Hie-Won Hann, Kris V. Kowdley, Steven-Huy B. Han, Albert D. Min, Truong-Sinh Leduc, The Management of Chronic Hepatitis B in Asian Americans, Digestive Diseases and Sciences, 2011, 56, 11, 3143

    CrossRef

  40. 40
    Ming-Hua Zheng, Ke-Qing Shi, Zhi-Juan Dai, Chao Ye, Yong-Ping Chen, A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients, Clinical Therapeutics, 2010, 32, 4, 649

    CrossRef

  41. 41
    Vandana Khungar, Steven-Huy Han, A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B, Current Hepatitis Reports, 2010, 9, 2, 75

    CrossRef

  42. You have free access to this content42
    J.D. Jia, G.B. Yao, Achieving ultimate control of hepatitis B infection in China: progress and challenges, Journal of Viral Hepatitis, 2010, 17,
  43. 43
    Erik De Clercq, Geoffrey Férir, Suzanne Kaptein, Johan Neyts, Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections, Viruses, 2010, 2, 6, 1279

    CrossRef

  44. 44
    Ju Hyun Shim, Han Chu Lee, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh, Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis, Journal of Hepatology, 2010, 52, 2, 176

    CrossRef

  45. 45
    Yun-Fan Liaw, George K. K. Lau, Jia-Horng Kao, Edward Gane, Hepatitis B e Antigen Seroconversion: A Critical Event in Chronic Hepatitis B Virus Infection, Digestive Diseases and Sciences, 2010, 55, 10, 2727

    CrossRef

  46. 46
    Sara Raimondi, Patrick Maisonneuve, Savino Bruno, Mario U. Mondelli, Is response to antiviral treatment influenced by hepatitis B virus genotype?, Journal of Hepatology, 2010, 52, 3, 441

    CrossRef

  47. You have free access to this content47
    J. Sun, J. L. Hou, Management of chronic hepatitis B: experience from China, Journal of Viral Hepatitis, 2010, 17,
  48. 48
    Helen Dakin, Carrie Fidler, Christie Harper, Mixed Treatment Comparison Meta-Analysis Evaluating the Relative Efficacy of Nucleos(t)ides for Treatment of Nucleos(t)ide-Naive Patients with Chronic Hepatitis B, Value in Health, 2010, 13, 8
  49. 49
    Hans Damerow, Lilly Yuen, Johannes Wiegand, Christine Walker, C.-Thomas Bock, Stephen Locarnini, Hans L. Tillmann, Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: Hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern, Journal of Medical Virology, 2010, 82, 11
  50. 50
    Wei Cai, Qing Xie, Baoyan An, Hui Wang, Xiaqiu Zhou, Guomin Zhao, Qing Guo, Ruiying Gu, Shisan Bao, On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients, Journal of Clinical Virology, 2010, 48, 1, 22

    CrossRef

  51. 51
    T. Asselah, O. Lada, P. Marcellin, Résultats des essais thérapeutiques dans l’hépatite chronique B, Antibiotiques, 2010, 12, 1, 42

    CrossRef

  52. 52
    Kate McKeage, Susan J. Keam, Telbivudine, Drugs, 2010, 70, 14, 1857

    CrossRef

  53. 53
    Gloria Woo, George Tomlinson, Yasunori Nishikawa, Matthew Kowgier, Morris Sherman, David K.H. Wong, Ba Pham, Wendy J. Ungar, Thomas R. Einarson, E. Jenny Heathcote, Murray Krahn, Tenofovir and Entecavir Are the Most Effective Antiviral Agents for Chronic Hepatitis B: A Systematic Review and Bayesian Meta-analyses, Gastroenterology, 2010, 139, 4, 1218

    CrossRef

  54. 54
    R. Pais, Y. Benhamou, Traitements à long terme de l’hépatite chronique B chez le patient co-infecté par le VIH, Gastroentérologie Clinique et Biologique, 2010, 34, S136

    CrossRef

  55. 55
    Richard J. Whitley, Antibiotic and Chemotherapy, 2010,

    CrossRef

  56. 56
    Brian Rha, David Kimberlin, Richard Whitley, Lennette's Laboratory Diagnosis of Viral Infections, 2010,

    CrossRef

  57. 57
    Yun–Fan Liaw, Edward Gane, Nancy Leung, Stefan Zeuzem, Yuming Wang, Ching Lung Lai, E. Jenny Heathcote, Michael Manns, Natalie Bzowej, Junqi Niu, Steven–Huy Han, Seong Gyu Hwang, Yilmaz Cakaloglu, Myron J. Tong, George Papatheodoridis, Yagang Chen, Nathaniel A. Brown, Efsevia Albanis, Karin Galil, Nikolai V. Naoumov, 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B, Gastroenterology, 2009, 136, 2, 486

    CrossRef

  58. 58
    Hong You, Hong Ma, Tianhui Liu, Min Cong, Ping Wang, Xiaojuan Ou, Xiaoming Wang, Jiangbo Ren, Hongyi Li, Baoen Wang, Jidong Jia, Different models of HBeAg seroconversion predicated by on-treatment ALT and HBV DNA profiles, Journal of Viral Hepatitis, 2009, 16, 12
  59. 59
    Yun-Fan Liaw, HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B, Hepatology International, 2009, 3, 3, 425

    CrossRef

  60. 60
    Kathryn Nash, Telbivudine in the treatment of chronic hepatitis B, Advances in Therapy, 2009, 26, 2, 155

    CrossRef

  61. 61
    Yanni YN Lui, Henry LY Chan, Treatment of chronic hepatitis B: focus on telbivudine, Expert Review of Anti-infective Therapy, 2009, 7, 3, 259

    CrossRef

  62. 62
    Yanni YN Lui, Henry LY Chan, A review of telbivudine for the management of chronic hepatitis B virus infection, Expert Opinion on Drug Metabolism & Toxicology, 2008, 4, 10, 1351

    CrossRef

  63. 63
    Frank Tacke, Christian Trautwein, Hepatitis B goes globe: Telbivudine as a new treatment option, Hepatology, 2008, 47, 5
  64. 64
    Manoj Kumar, Shiv K Sarin, Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection, Expert Review of Gastroenterology & Hepatology, 2008, 2, 4, 465

    CrossRef

  65. 65
    Mark A Feitelson, Marcia M Clayton, Helena MGPV Reis, Guoyi Wu, Eva Ping Lu, Pharmacotherapy of chronic viral hepatitis and hepatocellular carcinoma, Expert Opinion on Pharmacotherapy, 2008, 9, 13, 2233

    CrossRef

  66. 66
    Shirley M Tsunoda, Tarek Hassanein, Telbivudine for the treatment of hepatitis B disease, Future Virology, 2008, 3, 6, 517

    CrossRef

  67. 67
    Resat Ozaras, Hakan Leblebicioglu, Cafer Eroglu, To define virological response in hepatitis B e antigen–negative patients, Hepatology, 2008, 47, 4
  68. 68
    T. Asselah, O. Lada, N. Boyer, M. Martinot, P. Marcellin, Traitement de l’hépatite chronique B, Gastroentérologie Clinique et Biologique, 2008, 32, 8-9, 749

    CrossRef

  69. 69
    Piero Luigi Almasio, Calogero Cammà, Vito Di Marco, Antonio Craxì, Hepatitis B: Prognosis and Treatment,
  70. 70
    Shushan Zhao, Lanhua Tang, Xuegong Fan, Lizhang Chen, Telbivudine for chronic hepatitis B, The Cochrane Library,